We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+4.55%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$3.29B
AUM Growth
+$383M
Cap. Flow
+$337M
Cap. Flow %
10.23%
Top 10 Hldgs %
35.01%
Holding
141
New
13
Increased
43
Reduced
18
Closed
25

Top Buys

Rank Stock Value
1
ZGNX
Zogenix, Inc.
ZGNX
+$38.1M
2
TMX
Terminix Global Holdings, Inc.
TMX
+$35.9M
3
EXAS
Exact Sciences
EXAS
+$35.8M
4
SRPT icon
Sarepta Therapeutics
SRPT
+$33.8M
5
MYOV
Myovant Sciences Ltd.
MYOV
+$27.1M

Top Sells

Rank Stock Value
1
BLUE
bluebird bio
BLUE
+$34.5M
2
ALTR
Altair Engineering Inc
ALTR
+$23.1M
3
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
+$22.9M
4
OPLN
Openlane
OPLN
+$21.6M
5
QURE icon
uniQure
QURE
+$17.8M

Sector Composition

Rank Sector Weight
1 Healthcare 47.89%
2 Technology 19.59%
3 Industrials 8.32%
4 Consumer Discretionary 7.68%
5 Communication Services 3.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ASND icon
1
Ascendis Pharma A/S
ASND
$16B
$196M 5.95%
1,698,648
– –
SRPT icon
2
Sarepta Therapeutics
SRPT
$1.57B
$171M 5.19%
1,123,000
+277,832
+33% +$33.8M
SAGE
3
DELISTED
Sage Therapeutics
SAGE
$138M 4.2%
755,000
-50,000
-6% -$8.53M
ZGNX
4
DELISTED
Zogenix, Inc.
ZGNX
$136M 4.13%
2,841,300
+946,300
+50% +$38.1M
TWLO icon
5
Twilio
TWLO
$30B
$113M 3.43%
827,000
– –
TTD icon
6
Trade Desk
TTD
$8.48B
$110M 3.33%
4,810,000
– –
ROP icon
7
Roper Technologies
ROP
$38.8B
$78.4M 2.38%
214,000
+37,000
+21% +$13.1M
WCN
8
Waste Connections
WCN
$42.2B
$76.8M 2.34%
804,000
+202,000
+34% +$18.6M
W icon
9
Wayfair
W
$11.2B
$75.2M 2.28%
514,777
– –
LOW icon
10
Lowe's Companies
LOW
$117B
$58.7M 1.78%
581,800
+16,800
+3% +$1.77M
PANW icon
11
Palo Alto Networks
PANW
$270B
$58.5M 1.78%
1,722,000
+450,000
+35% +$16.8M
EXAS
12
DELISTED
Exact Sciences
EXAS
$58.4M 1.78%
495,000
+355,000
+254% +$35.8M
MTD icon
13
Mettler-Toledo International
MTD
$28.6B
$57.9M 1.76%
68,900
+20,900
+44% +$15.8M
AIMT
14
DELISTED
Aimmune Therapeutics
AIMT
$57.8M 1.76%
2,775,000
+813,000
+41% +$16.7M
XYL icon
15
Xylem
XYL
$27.3B
$57.1M 1.74%
682,900
+285,900
+72% +$22.8M
HUBS icon
16
HubSpot
HUBS
$12.2B
$54.1M 1.64%
317,000
– –
SPLK
17
DELISTED
Splunk Inc
SPLK
$53.8M 1.64%
428,000
– –
FIVN icon
18
FIVE9
FIVN
$2.11B
$51.3M 1.56%
1,000,000
+189,000
+23% +$9.59M
DNTH icon
19
Dianthus Therapeutics
DNTH
$5.84B
$50.8M 1.54%
218,452
+26,562
+14% +$6.57M
STML
20
DELISTED
Stemline Therapeutics, Inc.
STML
$48.9M 1.49%
3,192,727
+1,583,204
+98% +$22.9M
BPMC
21
DELISTED
Blueprint Medicines
BPMC
$43.6M 1.32%
462,000
– –
LRCX icon
22
Lam Research
LRCX
$367B
$42.6M 1.3%
2,270,000
– –
VMC icon
23
Vulcan Materials
VMC
$34.8B
$41.9M 1.27%
305,000
+46,000
+18% +$5.87M
CCI icon
24
Crown Castle
CCI
$33.3B
$41.6M 1.26%
319,000
+19,000
+6% +$2.44M
LII icon
25
Lennox International
LII
$14.4B
$39.6M 1.2%
144,000
– –
1
2 3 4 5

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q2 2019 Portfolio in Review

As of Q2 2019, Eventide Asset Management held 141 positions worth $3.29B, up 13% from $2.91B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Eventide Asset Management deployed $337M of net new capital in Q2 2019, opening 13 new positions and adding to 43 existing holdings. Its largest new stake was Terminix Global Holdings, Inc.: 698,000 shares worth $36.4M.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, up from 47% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was bluebird bio, an estimated $34.5M trimmed.

  • Eventide Asset Management's largest Q2 2019 buy was Terminix Global Holdings, Inc.: 698,000 shares worth $36.4M.
  • Eventide Asset Management added most to Zogenix, Inc. in Q2 2019, an estimated $38.1M increase.
  • Eventide Asset Management's biggest Q2 2019 reduction was bluebird bio, cutting an estimated $34.5M.
  • Eventide Asset Management fully exited Altair Engineering Inc in Q2 2019, selling an estimated $23.1M.
  • Eventide Asset Management's ten largest holdings make up 35% of its $3.29B portfolio in Q2 2019.
  • Eventide Asset Management opened 13 new positions and closed 25 in Q2 2019.
  • Eventide Asset Management's portfolio value rose 13% quarter-over-quarter to $3.29B.

Based on Eventide Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.